PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 72.60
-0.50 (-0.68%)
At close: Dec 5, 2025
PharmaEngine Revenue
PharmaEngine had revenue of 242.16M TWD in the quarter ending September 30, 2025, with 10.97% growth. This brings the company's revenue in the last twelve months to 2.51B, up 201.11% year-over-year. In the year 2024, PharmaEngine had annual revenue of 2.52B with 228.70% growth.
Revenue (ttm)
2.51B
Revenue Growth
+201.11%
P/S Ratio
4.16
Revenue / Employee
56.93M
Employees
44
Market Cap
10.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 1.76B | 228.70% |
| Dec 31, 2023 | 767.67M | 113.29M | 17.31% |
| Dec 31, 2022 | 654.38M | -452.00K | -0.07% |
| Dec 31, 2021 | 654.84M | -401.18M | -37.99% |
| Dec 31, 2020 | 1.06B | 741.97M | 236.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Pegavision | 6.90B |
| Center Laboratories | 1.57B |
| EirGenix | 936.18M |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |